About this trial
This study investigates the effects of a new supplement on sperm quality in men with poor sperm quality. Fifty patients will receive the supplement for three months, followed by semen analysis and assessment of sperm aging and mitochondrial function. Changes in sexual function and aging symptoms will also be evaluated.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Not meet the criteria of the 6th edition of the WHO manual for human semen analysis
BMI:18-30 kg/m2
Disqualifiers
Azoospermia
Varicocele
Chromosome anomaly
Malignancy
Trial design
Single group
Treatments tested in this trial
Male supplement
Dietary supplementParticipants will be administered supplements for a three-month treatment period
Treatment groups
Trial outcomes
Primary outcomes
Semen analysis
semen concentration, motility and morphology
Secondary outcomes
oxygen consumption of mitochondria
oxygen consumption rate
mitochondrial function
adenosine triphosphate production
sexual function
International Index of Erectile Function (IIEF-5): a diagnostic tool for erectile dysfunction. The scores for the IIEF-5 range from 5 to 25. Higher scores mean a worse outcome
aging symptoms
Aging Males Symptoms Scale (AMS): a simple and effective way to detect whether you may have andropause. Each item is rated on a scale of 1 to 5. There are 17 in total, so the minimum score is 17 and the maximum score is 85. Higher scores mean a worse outcome.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.